Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery, Inc.

Published June 29, 2009, 9:30 am, Business Wire via Yahoo! Finance

BURLINGAME, Calif.----Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced the signing of a definitive agreement with Antigen Discovery, Inc. to access ADi's proprietary high-throughput protein microarray screening system to discover novel disease-specific antigens to fuel Juvaris' vaccine pipeline.

Discover News | Full Story